Paper Review Records
All Paper Review Records
2 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
32
days
First-line pembrolizumab plus chemotherapy versus bevacizumab plus chemotherapy in response and survival outcomes in PD-L1-negative advanced non-squamous NSCLC: a retrospective comparative cohort study
Authors
Kuofang Huang; Shifei Pan; Huishu Dong; Haijiao Lu; Bo Yan; Jialin Qian; Tianqing ChuShow moreShow less
Affiliations
1. Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;; 2. Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;; 3. Clinical Research Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
50
days
PSMA6 drives non-small cell lung cancer progression by stabilizing NEDD8 and activating NF-κB signaling
Authors
Shiyang Deng; Zixuan Li; Nan Liu; Yue Wang; Jialu Sun; Bin Guan; Jiang DuShow moreShow less
Affiliations
1. Department of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, China;; 2. Department of Pathology, College of Basic Medical Science, China Medical University, Shenyang, China;; 3. Department of Clinical Nutrition, The First Affiliated Hospital of China Medical University, Shenyang, China;; 4. School of Stomatology, China Medical University, Shenyang, China;; 5. School of Health Management, China Medical University/Human Resources Department, The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
